In the BioHarmony Drug Report Database

"Preview" Icon

Thioguanine

Thioguanine (thioguanine) is a small molecule pharmaceutical. Thioguanine was first approved as Thioguanine on 1982-01-01. It is used to treat basophilic leukemia acute, bcr-abl positive chronic myelogenous leukemia, eosinophilic leukemia acute, neutrophilic leukemia chronic, and psoriasis in the USA. The pharmaceutical is active against inosine-5′-monophosphate dehydrogenase 2 and inosine-5′-monophosphate dehydrogenase 1. In addition, it is known to target 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase.

 

Trade Name

 

Thioguanine
 

Common Name

 

thioguanine
 

ChEMBL ID

 

CHEMBL727
 

Indication

 

basophilic leukemia acute, bcr-abl positive chronic myelogenous leukemia, eosinophilic leukemia acute, neutrophilic leukemia chronic, psoriasis
 

Drug Class

 

Image (chem structure or protein)

Thioguanine structure rendering